The evolution of risk-based safety: from TSA PreCheck to COVID-19 will be hosted by hc1 and Daon on January 19, 2021, 1 p.m. – 2:30 p.m. EST

By Sarah Virgil

Brad Bostic, chairman, and CEO of hc1, the bioinformatics leader in precision testing and prescribing, discusses the collaboration between hc1 and Quest Diagnostics, the largest provider of lab testing in the U.S.

Subscribe to the blog
Previous Post Transforming Lab Data into Personalized Healthcare Insights
Next Post The Future of Healthcare: “What Healthcare Can Learn from Amazon”, With Brad Bostic, CEO of hc1